510(k) Report

510(k) · Cleared

Cleared

Maglumi 2000 HCG/ß-HCG

K192547510(k) TraditionalCleared Jan 17, 2020122-day reviewClass II21 CFR 862.1155

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Shenzhen New Industries Biomedical Engineering Co., Ltd. · DHA System, Test, Human Chorionic Gonadotropin

Cleared on Jan 17, 2020 as substantially equivalent to K130020 (Beckman Coulter, Inc., 2013) after a 122-day review. Its family tree reaches back 2 generations to 1993.

Decided
Jan 17, 2020
Review
122 days
Class
Class II
Product code
DHA
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K925277 (1993). No later device cites it as a predicate yet.

  1. Root · 2 generations backK925277 Ciba Corning Acs HCG ImmunoassayCiba Corning Diagnostics Corp. · 1993
  2. 1 generation backK130020 Access Total BHCG (5TH IS)Beckman Coulter, Inc. · 2013
  3. This deviceK192547 Maglumi 2000 HCG/ß-HCGShenzhen New Industries Biomedical Engineering Co., Ltd. · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K925277Ciba Corning Acs HCG ImmunoassayCiba Corning Diagnostics Corp.1993—
−1K130020Access Total BHCG (5TH IS)Beckman Coulter, Inc.2013—
0 (this device)K192547Maglumi 2000 HCG/ß-HCGShenzhen New Industries Biomedical Engineering Co., Ltd.2020—
FIG. 1 — Lineage of K192547, 1993–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DHA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DHA device

  1. #1 K233581 VITROS Immunodiagnostic Products Total ß-hCG…score 7.6 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K130020Access Total BHCG (5TH IS)
Summary page 4
…CFR # Product Name DHA 862.1155 Human Chorionic Gonadotropin (HCG) Test System 5. Predicate Devices: K130020, Beckman Access Total β-HCG (5th IS) Assay 6. Device Description: MAGLUMI 2000 HCG/β-HCG kit consists of the following reage…
Beckman Coulter, Inc.2013—

Also cleared against K130020: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 3 companies; a new generation was cleared every 20.5 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K130020.

How does its category compare?

All DHA devices

DHA System, Test, Human Chorionic Gonadotropin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · DHA

1in 2024

2007: 22008: 12009: 12013: 22015: 12017: 22019: 12020: 12021: 32022: 12023: 32024: 1
2007high 3 (2021) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DHA

63in 2023

2021: 289 days median2023: 63 days median
2007high 289 (2021) · low 63 (2023)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DHA

2in 2022

2010: 22015: 22018: 12022: 2
2007high 2 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DHA

234in 2025

2007: 642008: 992009: 1962010: 1792011: 4782012: 2772013: 2442014: 1192015: 522016: 552017: 1012018: 1032019: 1522020: 1152021: 2102022: 1852023: 1942024: 2612025: 234
2007high 478 (2011) · low 52 (2015)2025

MAUDE reports naming product code DHA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—064
20081—099
20091—0196
20100—2179
20110—0478
20120—0277
20132—0244
20140—0119
20151—252
20160—055
20172—0101
20180—1103
20191—0152
20201—0115
202132890210
20221—2185
20233630194
20241—0261
20250—0234
20260—0—

What is it indicated for?

MAGLUMI 2000 HCG/β-HCG is an in vitro chemiluminescence immunoassay for the quantitative determination of total beta human chorionic gonadotropin (total β-hCG) in human serum. The measurement of total β-hCG is used as an aid in the early detection of pregnancy.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K192547: Maglumi 2000 HCG/ß-HCG.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K192547

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026